Bolt Biotherapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BOLT and other ETFs, options, and stocks.About BOLT
Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. Its pipeline includes BDC-1001, a HER2-targeting Boltbody Immune-Stimulating Antibody Conjugate (ISAC), BDC-3042, a myeloid-modulating antibody, and multiple Boltbody ISAC collaboration programs.
CEOWilliam P. Quinn
CEOWilliam P. Quinn
Employees52
Employees52
HeadquartersRedwood City, California
HeadquartersRedwood City, California
Founded2015
Founded2015
Employees52
Employees52
BOLT Key Statistics
Market cap10.10M
Market cap10.10M
Price-Earnings ratio-0.24
Price-Earnings ratio-0.24
Dividend yield—
Dividend yield—
Average volume38.68K
Average volume38.68K
High today$5.38
High today$5.38
Low today$5.00
Low today$5.00
Open price$5.20
Open price$5.20
Volume41.85K
Volume41.85K
52 Week high$12.60
52 Week high$12.60
52 Week low$4.41
52 Week low$4.41
Stock Snapshot
The current Bolt Biotherapeutics(BOLT) stock price is $5.33, with a market capitalization of 10.1M. The stock trades at a price-to-earnings (P/E) ratio of -0.24.
As of 2025-12-28, Bolt Biotherapeutics(BOLT) stock has fluctuated between $5.00 and $5.38. The current price stands at $5.33, placing the stock +6.6% above today's low and -1.0% off the high.
Bolt Biotherapeutics(BOLT) shares are trading with a volume of 41.85K, against a daily average of 38.68K.
In the last year, Bolt Biotherapeutics(BOLT) shares hit a 52-week high of $12.60 and a 52-week low of $4.41.
In the last year, Bolt Biotherapeutics(BOLT) shares hit a 52-week high of $12.60 and a 52-week low of $4.41.
People also own
Based on the portfolios of people who own BOLT. This list is generated using Robinhood data, and it’s not a recommendation.